| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-24 |
4 |
S |
$3.06 |
$14,153 |
I/I |
(4,625) |
775,228 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-02 |
4 |
B |
$2.10 |
$14,232 |
D/D |
6,779 |
4,211,288 |
2.37 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-05 |
4 |
S |
$2.06 |
$14,420 |
I/I |
(7,000) |
701,858 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-06 |
4 |
S |
$2.96 |
$14,507 |
I/I |
(4,901) |
856,115 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-09 |
4 |
B |
$2.00 |
$14,600 |
I/I |
7,300 |
790,445 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-17 |
4 |
S |
$2.90 |
$15,105 |
I/I |
(5,212) |
532,082 |
0 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-30 |
4 |
B |
$1.36 |
$16,150 |
I/I |
11,849 |
20,575,061 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-11-21 |
4 |
S |
$1.13 |
$16,420 |
I/I |
(14,531) |
166,995 |
0 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2022-12-15 |
4/A |
B |
$1.65 |
$16,476 |
I/I |
10,000 |
20,319,189 |
2.17 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-26 |
4 |
B |
$1.97 |
$16,629 |
I/I |
8,448 |
781,945 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-05 |
4 |
S |
$2.52 |
$16,894 |
I/I |
(6,696) |
632,517 |
0 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2022-12-16 |
4 |
B |
$1.70 |
$17,000 |
I/I |
10,000 |
20,339,189 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-07-27 |
4 |
S |
$0.86 |
$17,074 |
I/I |
(19,748) |
4,065,044 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-08 |
4 |
S |
$2.64 |
$18,014 |
I/I |
(6,824) |
625,693 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-28 |
4 |
B |
$2.11 |
$18,936 |
I/I |
8,970 |
440,781 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-09 |
4 |
S |
$1.88 |
$19,086 |
I/I |
(10,152) |
675,902 |
0 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-31 |
4 |
B |
$1.35 |
$20,006 |
I/I |
14,792 |
20,589,853 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-25 |
4 |
S |
$2.42 |
$20,345 |
I/I |
(8,394) |
489,347 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-03 |
4 |
B |
$2.09 |
$20,871 |
I/I |
10,000 |
613,254 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-16 |
4 |
B |
$1.99 |
$20,981 |
I/I |
10,562 |
731,162 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-13 |
4 |
B |
$1.99 |
$20,991 |
I/I |
10,572 |
801,817 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-10 |
4 |
S |
$2.65 |
$21,184 |
I/I |
(8,006) |
617,687 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-19 |
4 |
S |
$2.73 |
$21,493 |
I/I |
(7,876) |
513,373 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-22 |
4 |
B |
$1.99 |
$21,517 |
I/I |
10,818 |
767,297 |
1.5 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-26 |
4 |
B |
$0.92 |
$21,620 |
I/I |
23,500 |
4,792,772 |
1.5 |
- |
|
634 Records found
|
|
Page 9 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
